Cargando…

The Association Between Long-Term Acenocoumarol Treatment and Vitamin D Deficiency

OBJECTIVE: Both vitamin D and K2 are involved in a number of metabolic processes, including bone metabolism; however, associations between the vitamins are not fully understood. The aim of the study was to evaluate serum concentrations of 25-hydroxyvitamin D [25(OH)D] in adult patients receiving lon...

Descripción completa

Detalles Bibliográficos
Autores principales: Sawicka-Powierza, Jolanta, Konstantynowicz, Jerzy, Jablonska, Ewa, Zelazowska-Rutkowska, Beata, Jelski, Wojciech, Abramowicz, Pawel, Sasinowski, Caroline, Chlabicz, Slawomir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945821/
https://www.ncbi.nlm.nih.gov/pubmed/29780360
http://dx.doi.org/10.3389/fendo.2018.00226
_version_ 1783322066059001856
author Sawicka-Powierza, Jolanta
Konstantynowicz, Jerzy
Jablonska, Ewa
Zelazowska-Rutkowska, Beata
Jelski, Wojciech
Abramowicz, Pawel
Sasinowski, Caroline
Chlabicz, Slawomir
author_facet Sawicka-Powierza, Jolanta
Konstantynowicz, Jerzy
Jablonska, Ewa
Zelazowska-Rutkowska, Beata
Jelski, Wojciech
Abramowicz, Pawel
Sasinowski, Caroline
Chlabicz, Slawomir
author_sort Sawicka-Powierza, Jolanta
collection PubMed
description OBJECTIVE: Both vitamin D and K2 are involved in a number of metabolic processes, including bone metabolism; however, associations between the vitamins are not fully understood. The aim of the study was to evaluate serum concentrations of 25-hydroxyvitamin D [25(OH)D] in adult patients receiving long-term acenocoumarol (AC) treatment. PARTICIPANTS AND METHODS: In this cross-sectional study, 58 Caucasian patients (31 women, 27 men) with a median age of 65 years receiving long-term AC therapy were evaluated and compared with 35 age- and gender-matched healthy controls. The AC treatment was used due to recurrent venous thromboembolism (34.5%), atrial fibrillation (31%), or mechanical heart valve prostheses (34.5%). Medical records and a questionnaire were used to obtain information about chronic diseases, smoking habits, and the duration of therapy and weekly dose of AC. Anthropometric measurements were performed, and serum concentration of 25(OH)D and total alkaline phosphatase (ALP) activity were measured. RESULTS: Among the 58 patients receiving long-term AC treatment, a high proportion (46.6%) demonstrated significant vitamin D deficiency with concentrations of 25(OH)D lower than 20 ng/mL. The median concentration of 25(OH)D in subjects receiving AC was significantly lower compared to the control group [20.4 (17.4; 26.1) vs. 28.2 (24; 32.7); p < 0.001]. No differences were found between women and men receiving AC therapy. In patients receiving AC, a negative correlation was found between the concentration of 25(OH)D and the weekly dose of AC (r = −0.337, p = 0.01). Patients with concentrations of 25(OH)D < 20 ng/mL were found to have a significantly higher median dose of AC, compared to those with concentrations of 25(OH)D ≥ 20 ng/mL [21 (17; 31) vs. 17 (12; 28); p = 0.045]. CONCLUSION: In conclusion, treatment with AC is associated with low 25-hydroxyvitamin D levels, although the path leading to this phenomenon is not entirely clear. Long-term administration of AC in adults may increase the risk of chronic vitamin D deficiency, thus, effective supplementation of vitamin D in these individuals needs careful consideration.
format Online
Article
Text
id pubmed-5945821
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-59458212018-05-18 The Association Between Long-Term Acenocoumarol Treatment and Vitamin D Deficiency Sawicka-Powierza, Jolanta Konstantynowicz, Jerzy Jablonska, Ewa Zelazowska-Rutkowska, Beata Jelski, Wojciech Abramowicz, Pawel Sasinowski, Caroline Chlabicz, Slawomir Front Endocrinol (Lausanne) Endocrinology OBJECTIVE: Both vitamin D and K2 are involved in a number of metabolic processes, including bone metabolism; however, associations between the vitamins are not fully understood. The aim of the study was to evaluate serum concentrations of 25-hydroxyvitamin D [25(OH)D] in adult patients receiving long-term acenocoumarol (AC) treatment. PARTICIPANTS AND METHODS: In this cross-sectional study, 58 Caucasian patients (31 women, 27 men) with a median age of 65 years receiving long-term AC therapy were evaluated and compared with 35 age- and gender-matched healthy controls. The AC treatment was used due to recurrent venous thromboembolism (34.5%), atrial fibrillation (31%), or mechanical heart valve prostheses (34.5%). Medical records and a questionnaire were used to obtain information about chronic diseases, smoking habits, and the duration of therapy and weekly dose of AC. Anthropometric measurements were performed, and serum concentration of 25(OH)D and total alkaline phosphatase (ALP) activity were measured. RESULTS: Among the 58 patients receiving long-term AC treatment, a high proportion (46.6%) demonstrated significant vitamin D deficiency with concentrations of 25(OH)D lower than 20 ng/mL. The median concentration of 25(OH)D in subjects receiving AC was significantly lower compared to the control group [20.4 (17.4; 26.1) vs. 28.2 (24; 32.7); p < 0.001]. No differences were found between women and men receiving AC therapy. In patients receiving AC, a negative correlation was found between the concentration of 25(OH)D and the weekly dose of AC (r = −0.337, p = 0.01). Patients with concentrations of 25(OH)D < 20 ng/mL were found to have a significantly higher median dose of AC, compared to those with concentrations of 25(OH)D ≥ 20 ng/mL [21 (17; 31) vs. 17 (12; 28); p = 0.045]. CONCLUSION: In conclusion, treatment with AC is associated with low 25-hydroxyvitamin D levels, although the path leading to this phenomenon is not entirely clear. Long-term administration of AC in adults may increase the risk of chronic vitamin D deficiency, thus, effective supplementation of vitamin D in these individuals needs careful consideration. Frontiers Media S.A. 2018-05-04 /pmc/articles/PMC5945821/ /pubmed/29780360 http://dx.doi.org/10.3389/fendo.2018.00226 Text en Copyright © 2018 Sawicka-Powierza, Konstantynowicz, Jablonska, Zelazowska-Rutkowska, Jelski, Abramowicz, Sasinowski and Chlabicz. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Sawicka-Powierza, Jolanta
Konstantynowicz, Jerzy
Jablonska, Ewa
Zelazowska-Rutkowska, Beata
Jelski, Wojciech
Abramowicz, Pawel
Sasinowski, Caroline
Chlabicz, Slawomir
The Association Between Long-Term Acenocoumarol Treatment and Vitamin D Deficiency
title The Association Between Long-Term Acenocoumarol Treatment and Vitamin D Deficiency
title_full The Association Between Long-Term Acenocoumarol Treatment and Vitamin D Deficiency
title_fullStr The Association Between Long-Term Acenocoumarol Treatment and Vitamin D Deficiency
title_full_unstemmed The Association Between Long-Term Acenocoumarol Treatment and Vitamin D Deficiency
title_short The Association Between Long-Term Acenocoumarol Treatment and Vitamin D Deficiency
title_sort association between long-term acenocoumarol treatment and vitamin d deficiency
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945821/
https://www.ncbi.nlm.nih.gov/pubmed/29780360
http://dx.doi.org/10.3389/fendo.2018.00226
work_keys_str_mv AT sawickapowierzajolanta theassociationbetweenlongtermacenocoumaroltreatmentandvitaminddeficiency
AT konstantynowiczjerzy theassociationbetweenlongtermacenocoumaroltreatmentandvitaminddeficiency
AT jablonskaewa theassociationbetweenlongtermacenocoumaroltreatmentandvitaminddeficiency
AT zelazowskarutkowskabeata theassociationbetweenlongtermacenocoumaroltreatmentandvitaminddeficiency
AT jelskiwojciech theassociationbetweenlongtermacenocoumaroltreatmentandvitaminddeficiency
AT abramowiczpawel theassociationbetweenlongtermacenocoumaroltreatmentandvitaminddeficiency
AT sasinowskicaroline theassociationbetweenlongtermacenocoumaroltreatmentandvitaminddeficiency
AT chlabiczslawomir theassociationbetweenlongtermacenocoumaroltreatmentandvitaminddeficiency
AT sawickapowierzajolanta associationbetweenlongtermacenocoumaroltreatmentandvitaminddeficiency
AT konstantynowiczjerzy associationbetweenlongtermacenocoumaroltreatmentandvitaminddeficiency
AT jablonskaewa associationbetweenlongtermacenocoumaroltreatmentandvitaminddeficiency
AT zelazowskarutkowskabeata associationbetweenlongtermacenocoumaroltreatmentandvitaminddeficiency
AT jelskiwojciech associationbetweenlongtermacenocoumaroltreatmentandvitaminddeficiency
AT abramowiczpawel associationbetweenlongtermacenocoumaroltreatmentandvitaminddeficiency
AT sasinowskicaroline associationbetweenlongtermacenocoumaroltreatmentandvitaminddeficiency
AT chlabiczslawomir associationbetweenlongtermacenocoumaroltreatmentandvitaminddeficiency